ADS:
Prostate adenoma is a proliferation of glandular epithelial tissue of a benign organ with a subsequent pathological increase in its size. Currently, the disease is defined by the term benign hyperplasia, also known as fibroadenoma and adenomatous hypertrophy. To eliminate confusion and speed up the recognition of pathology, the World Health Organization has developed the International Classification of Diseases Handbook, or ICD, which is periodically supplemented and amended. The latest changes to the system were approved in 2010.
In the directory, disorders of various organ systems are included in certain sections, and the systems are indicated in Latin letters, and the organs themselves and their pathologies are encoded with numbers. Diseases of the male reproductive organs are included in the ICD 10 under the codes N40 - N51, and each disease is assigned its own unique code. How is benign prostatic hyperplasia, which practicing urologists and andrologists face daily, recognized?
This pathology in the ICD 10 is designated by the code N40 and is included in the XIV class of diseases. In total, twenty-one classes are distinguished in the classification, the first seventeen of which include painful conditions of internal organs. Many patients mistakenly believe that prostatitis, other forms of inflammatory lesions of the gland and BPH are included in the ICD under the same code. This is not so: Prostate adenoma code for ICD 10 N40, while prostatitis is designated N41.
As the main reason for the development of adenoma, experts identify age-related changes in the hormonal background, which manifest themselves in a decrease in testosterone levels. With the exception of isolated cases associated with a hereditary predisposition, the disorder is diagnosed in men over fifty years of age. Pathology is detected in almost half of the representatives of this age group, and after eighty, all patients suffer from adenoma and urination disorders.
Prostate adenoma is included in the international directory of classification of diseases in the group of pathologies of the prostate, XIV class of diseases of the male reproductive system under the code N40. Other neoplasms of the gland of a benign nature are indicated by other codes.
In older men, the production of 5-a-reductase, an enzyme that is involved in the conversion of testosterone to dihydrotestosterone, is enhanced. This active compound causes active growth of the glandular epithelium of the prostate. The following factors also contribute to the occurrence of benign hyperplasia:
It has been proven that pathology does not develop as a result of malnutrition, lack of intake of essential macro- and microelements, smoking and drinking alcoholic beverages. The impact of these factors complicates the course of the disease, accelerates the increase in the size of the gland.
Men after the age of forty need to know not only that prostate adenoma ICD 10 is designated as N40, but also the symptoms and stages of this common disease. It is especially important to be able to distinguish between warning signs that are mild at the initial stage of the pathology.
The main symptom is a violation of urination, depending on the degree and severity of which the following stages of the disease are distinguished:
Studies have shown that blacks are more likely to suffer from benign prostatic hyperplasia. The lowest incidence of the disease is observed in the Japanese and Chinese, which is explained by the use of foods containing a large amount of phytosterols.
The following methods allow to identify BPH code according to ICD 10 N40: